MGMT and glioblastoma: Molecular markers of glioblastoma such as methylated O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation was seen in 16 out of the 33 patients evaluated (48%) and expression of immunological markers such as TNF-a, IL-1β, and IL-6 was considered in one patient [33,38].